Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biopharmaceutical company headquartered in Petah-Tikva, Israel, focused on developing innovative small molecule therapeutics targeting a range of serious illnesses, including cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. With a robust pipeline anchored by clinical trials, Can-Fite is committed to addressing unmet medical needs through its proprietary drug candidates. The company’s technology platform leverages the unique mechanisms of action of its compounds to optimize therapeutic outcomes, positioning Can-Fite as a potentially significant player in the biopharmaceutical landscape.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

26 BEN GURION STREET, RAMAT GAN, ISRAEL, 5257346

December

$15.2 Million

-$8.91 Million

0.0

0.0

$0.00

0.0%

0.042